The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Xalatan 50 micrograms/mL eye drops, solution

PCO Manufacturing Ltd.PPA0465/267/001

Main Information

Trade NameXalatan 50 micrograms/mL eye drops, solution
Active SubstancesLatanoprost
Dosage FormEye drops, solution
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/267/001

Group Information

ATC CodeS01EE Prostaglandin analogues1)
S01EE01 latanoprost


Withdrawn Date31/01/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThis authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0822/140/001.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0096-152-045
Interchangeable List DocumentPDF of Interchangeable List
« Back